₹923.05
+₹48.35 (+5.53%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹49,276 Cr
P/E
85.52
ROE
19.45%
ROCE
26.70%
About Anthem Biosciences Ltd
Anthem Biosciences operates in biotechnology sector and its business activities includes, discover, develop, manufacture, and commercialize biopharmaceutical products that address significant unmet needs and provide biological solutions to improve industrial performance in all areas.
Founded
2006
CEO
Ajay Bhardwaj
Employees
3,302
HQ
Bangalore, India
About Anthem Biosciences Ltd
Anthem Biosciences operates in biotechnology sector and its business activities includes, discover, develop, manufacture, and commercialize biopharmaceutical products that address significant unmet needs and provide biological solutions to improve industrial performance in all areas.
Founded:2006
CEO:Ajay Bhardwaj
Employees:3,302
HQ:Bangalore, India
Finished Products
1Export Sales
₹2,639.66Cr2Domestic Sales
₹618.53CrRaw Materials
1Rawmaterial Consumed
₹1,468.85CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹927
52W Low
₹579
Volume1.85M
Avg VolumeN/A
Beta0.67
Dividend Yield0.23%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
85.52x
Valuation
P/B Ratio
16.19x
Valuation
EPS
₹10.23
Valuation
Dividend Yield
0.23%
Valuation
ROE
19.45%
Profitability
ROCE
26.70%
Profitability
Revenue by Segment
Contribution & growth by business line
CRDMO
+17.7%83.4%
₹1,772.75 Cr
Speciality Ingredients
+3.9%16.6%
₹351.59 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
14.9%
International
85.1%
Europe53.9%
North America (USA)27.3%
India14.9%
Rest of asia and others3.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
14.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.